Hypertrophic Scar.
Bharadia SK, Burnett L, Gabriel V.
Phys Med Rehabil Clin N Am. 2023 Nov;34(4):783-798. doi: 10.1016/j.pmr.2023.05.002. Epub 2023 Jul 11.
The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol.
Ogawa R, Dohi T, Tosa M, Aoki M, Akaishi S.
J Nippon Med Sch. 2021 Mar 11;88(1):2-9. doi: 10.1272/jnms.JNMS.2021_88-106. Epub 2020 Aug 1.
Hypertrophic scar.
Gabriel V.
Phys Med Rehabil Clin N Am. 2011 May;22(2):301-10, vi. doi: 10.1016/j.pmr.2011.02.002.
[Hypertrophic scar: What to do?].
Mert S, Giunta R.
MMW Fortschr Med. 2024 Jun;166(11):50-51. doi: 10.1007/s15006-024-3928-x.
Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring.
Yin J, Zhang S, Yang C, Wang Y, Shi B, Zheng Q, Zeng N, Huang H.
Front Immunol. 2022 Oct 17;13:1028410. doi: 10.3389/fimmu.2022.1028410. eCollection 2022.
Hypertrophic scar management.
Edwards J.
Br J Nurs. 2022 Nov 10;31(20):S24-S31. doi: 10.12968/bjon.2022.31.20.S24.
Update on Hypertrophic Scar Management in Burn Patients.
Ogawa R.
Clin Plast Surg. 2024 Jul;51(3):349-354. doi: 10.1016/j.cps.2024.02.001. Epub 2024 Mar 21.
Current potential therapeutic strategies targeting the TGF-beta/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
Zhang T, Wang XF, Wang ZC, Lou D, Fang QQ, Hu YY, Zhao WY, Zhang LY, Wu LH, Tan WQ.
Biomed Pharmacother. 2020 Sep;129:110287. doi: 10.1016/j.biopha.2020.110287. Epub 2020 Jun 12.
HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation.
Gao Y, Liu Y, Zheng D, Ho C, Wen D, Sun J, Huang L, Liu Y, Li Q, Zhang Y.
Int J Biol Sci. 2022 Sep 11;18(15):5724-5739. doi: 10.7150/ijbs.76140. eCollection 2022.
Scar massage for hypertrophic burns scarring-A systematic review.
Ault P, Plaza A, Paratz J.
Burns. 2018 Feb;44(1):24-38. doi: 10.1016/j.burns.2017.05.006. Epub 2017 Jun 29.
